期刊文献+

探讨多索茶碱与噻托溴铵粉联合治疗慢性阻塞性肺疾病对肺功能的影响 被引量:28

Study of Doxofylline and Tiotropium Bromide Powder Combined with the Treatment of Chronic Obstructive Pulmonary Disease Effect on Lung Function
下载PDF
导出
摘要 目的探讨多索茶碱与噻托溴铵粉联合治疗慢阻肺对肺功能的影响。方法方便选取该院自2013年12月—2015年12月收治的慢阻肺患者48例,以随机分配法对患者进行分组处理,观察组及对照组患者均为24例。对照组患者单纯以多索茶碱进行治疗;观察组患者在多索茶碱治疗基础上联合噻托溴铵粉进行治疗,分析比较两组患者的临床疗效。结果 1治疗总有效率比较:观察组为95.8%(23/24);对照组为75%(18/24),组间比较差异有统计学意义(P<0.05);2肺功能指标改善上:治疗后,以观察组患者的FVC、FEV1、FEV1/FVC指标改善更显著,组间比较差异有统计学意义P<0.05。结论多索茶碱与噻托溴铵粉联合治疗慢阻肺临床效果显著,优于单项多索茶碱治疗。 Objective To investigate the effect of doxofylline and tiotropium bromide powder combined with the treatment of chronic obstructive pulmonary disease effect on lung function. Methods In our hospital from December 2013 to December 2015, 48 patients with chronic obstructive pulmonary disease were divided into two groups. The patients in the observation group and the control group were treated with 24 cases. The control group were treated with doxofylline treatment; observa-tion group patients in doxofylline treatment based on combined with thiazide tiotropium bromide powder treatment and analysis were compared between the two groups of patients with clinical curative effect. Results ①The total efficiency of treatment:observation group was 95.8%(23/24);control group was 75%(18/24), comparison between the two groups (P〈0.05); ② pulmonary function improvement: after treatment, to observation group patients with FVC, FEV1, FEV1 / FVC in-dex improved more significantly, the group is P 〈 0.05. Conclusion Doxofylline and tiotropium bromide powder combined treatment of COPD clinical effect significantly, better than the single doxofylline treatment.
作者 马小梅
出处 《中外医疗》 2016年第19期141-142,共2页 China & Foreign Medical Treatment
关键词 多索茶碱 噻托溴铵粉 慢阻肺 肺功能 影响 Doxofylline Tiotropium powder Chronic obstructive pulmonary disease Pulmonary function Influence
  • 相关文献

参考文献8

二级参考文献44

  • 1刘敏.噻托溴铵治疗76例慢阻肺合并支气管扩张临床疗效观察[J].医学信息(医学与计算机应用),2014,0(12):190-190. 被引量:4
  • 2冯亚洲.应用氧气驱动联合药物治疗慢阻肺急性发作的临床疗效观察[J].求医问药(下半月),2013(7):54-55. 被引量:9
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8235
  • 4R enn ard S,Decram erM,C alverley PMA. Im pact of COPD in North Am erica and Eu rope in 2000:sub jects 1 perspect ive of Confronting COPD In ternat iona l Survey[J].Eu r R espir J,2002,(06):799-805.
  • 5Celli BR,Machee W,Agusti A. Standards for the diagnosis ang treatment of paitients with COPD:a summary of the ATS/ERS position paper[J].Eur Pespir J,2004,(06):832-840.
  • 6PieperM,P,Chaudhary NI,Park JE. Acetylcholine-induced proliferations of fibrob lasts in vitro is inhibited by tiotropium brunide life[J].Science,2007,(24-25):2270-2273.
  • 7T a s h k i n P D,Celli B,SennS. A 4-year teail of tiotropium in chronic obstructive pulmonary diease[J].New England Journal of Medicine,2008,(15):1534-1554.
  • 8J GOLD Executive Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary dis- ease[J] (Revised 2014).
  • 9Global Initiative for Asthma. The global strategy for astllma man- agement and prevention[J]. (Revised 2014).
  • 10Bos IS, Gosens R, Zuidhof AB, et al. Inhibition of allergen-in- duced airway remodelling by tiotropium and budesonide : a compar- ison[J]. Eur Respir J, 2007 Oct;30(4) :653 -61.

共引文献231

同被引文献136

引证文献28

二级引证文献200

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部